Thermo Fisher Scientific is closely monitoring the COVID-19 situation as it continues to evolve. The health and safety of our employees and our ability to ensure the delivery of medicines to patients is our top priority. Click Here for our latest business updates.
Pete & Lisa Beerse
Hope & HeroesWatch Our Latest Patient Video »
Designed specifically for new and emerging companies such as Kaleido Biosciences, The Quick to Care™ program is an integrated solution that combines drug substance and drug product development, clinical manufacturing, forecasting, demand planning and clinical trial supply execution managed by a single program manager. Learn how Kaleido Biosciences was able to simplify their supply chain to meet their aggressive timeline with the Quick to Care™ program.
Our CDMO and clinical services offerings are now unified under the Patheon brand. Learn more about our full breadth of capabilities for pharma and biotech companies of all sizes, and how we can take your discovery from clinical to commercial.
Sanjay Konagurthu, Ph.D.
Sr. Director, PDS Global
Science & Technologies
Chemistry & ConvictionRead Stories About Our People »
Our global network of pharmaceutical development and manufacturing facilities allows Thermo Fisher Scientific the collaboration and reach to ensure your project gets completed quickly and accurately.
30 September, 2020CPhI Japan – Postponed This event has been postponed.
30 March, 2020Gene Therapy for Rare Disorders
Date: March 20-April 2, 2020
Location: Boston, MA
01 April, 2020Synergistix Collaboration Conference Partner Program – Canceled
This event has been canceled